Synopsis: Telangana’s Drug Control Lab flagged 10 NSQ drugs in September 2025, including two TGMSIDC-supplied for govt hospitals. Sunrise Labs’ Rabeprazole had less than 50% active ingredient, leading to blacklist and recall. Nationwide, CDSCO reported 112 NSQ, 2 spurious; Himachal dominated failures. Antibiotic, cardiac, and injectable meds raised resistance and safety alarms.

The Telangana Drug Control Laboratory has identified 10 Not of Standard Quality (NSQ) pharmaceutical products in its September 2025 testing report, according to the Central Drugs Standard Control Organisation (CDSCO) latest NSQ release.

These drugs include two drugs procured by the Telangana Medical Services and Infrastructure Development Corporation (TGMSIDC) for government hospitals.

Among the failures, a loca

See Full Page